Inventiva S.A. (IVA.PA)

EUR 3.24

(2.37%)

Operating Expenses Summary of Inventiva S.A.

  • Inventiva S.A.'s latest annual operating expenses in 2023 was 120.18 Million EUR , up 77.46% from previous year.
  • Inventiva S.A.'s latest quarterly operating expenses in 2024 Q2 was 54.98 Million EUR , down 0.0% from previous quarter.
  • Inventiva S.A. reported a annual operating expenses of 69.28 Million EUR in annual operating expenses 2022, up 23.05% from previous year.
  • Inventiva S.A. reported a annual operating expenses of 56.3 Million EUR in annual operating expenses 2021, up 87.14% from previous year.
  • Inventiva S.A. reported a quarterly operating expenses of 60.06 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Inventiva S.A. reported a quarterly operating expenses of 122.95 Million EUR for 2023 FY, up 77.46% from previous quarter.

Annual Operating Expenses Chart of Inventiva S.A. (2023 - 2013)

Historical Annual Operating Expenses of Inventiva S.A. (2023 - 2013)

Year Operating Expenses Operating Expenses Growth
2023 120.18 Million EUR 77.46%
2022 69.28 Million EUR 23.05%
2021 56.3 Million EUR 87.14%
2020 30.09 Million EUR -16.91%
2019 36.21 Million EUR -0.55%
2018 36.41 Million EUR 34.93%
2017 26.98 Million EUR 25.55%
2016 21.49 Million EUR 8.84%
2015 19.74 Million EUR 17.91%
2014 16.75 Million EUR 7.85%
2013 15.53 Million EUR 0.0%

Peer Operating Expenses Comparison of Inventiva S.A.

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR -2777.329%
ABIVAX Société Anonyme 127.37 Million EUR 5.645%
Adocia SA 15.62 Million EUR -668.994%
Aelis Farma SA 18.81 Million EUR -538.642%
Biophytis S.A. 14.33 Million EUR -738.526%
Advicenne S.A. 8.21 Million EUR -1363.007%
genOway Société anonyme 16.73 Million EUR -618.031%
IntegraGen SA 5.35 Million EUR -2145.414%
Medesis Pharma S.A. 1.56 Million EUR -7581.717%
Neovacs S.A. 10.34 Million EUR -1061.942%
NFL Biosciences SA 4.37 Million EUR -2647.515%
Plant Advanced Technologies SA 2.76 Million EUR -4246.927%
Quantum Genomics Société Anonyme 1.71 Million EUR -6895.835%
Sensorion SA 27.05 Million EUR -344.25%
Theranexus Société Anonyme 3 Million EUR -3899.551%
TME Pharma N.V. 5.49 Million EUR -2086.393%
Valbiotis SA 9.86 Million EUR -1117.813%
TheraVet SA 1.64 Million EUR -7209.192%
Valerio Therapeutics Société anonyme 20.32 Million EUR -491.467%
DBV Technologies S.A. 89.4 Million EUR -34.428%
Genfit S.A. 54.8 Million EUR -119.302%
GeNeuro SA 14.35 Million EUR -737.107%
Innate Pharma S.A. 64.57 Million EUR -86.133%
MaaT Pharma SA 21.59 Million EUR -456.468%
MedinCell S.A. 32.92 Million EUR -265.063%
Nanobiotix S.A. 58.92 Million EUR -103.957%
OSE Immunotherapeutics SA 23.58 Million EUR -409.5%
Poxel S.A. 28.76 Million EUR -317.82%
GenSight Biologics S.A. 32.66 Million EUR -267.991%
Transgene SA 31.23 Million EUR -284.829%
Valneva SE 134.92 Million EUR 10.923%